Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
clinical trials
5
×
europe
5
×
europe blog main
life sciences
national blog main
brexit
drugs
falsified medicines
innovation
labeling
mhra
regulations
uk
eli lilly
europe top stories
fda
national
abbvie
alkermes
allergan
boehringer ingelheim
boston blog main
boston top stories
buprenorphine
cariprazine
empagliflozin
felipe jain
indiana blog main
indiana top stories
jess fiedorowicz
jessica jeffrey
karim calis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national institutes of health (nih)
national top stories
new york blog main
What
brexit
charting
choppy
course
dynamic
end
medicines
period
plans
post
regulation
regulatory
reveals
transition
uk
drug
fda
alkermes
antipsychotic
approval
benefits
bid
boehringer
caveats
commonly
designed
diabetes
effect
eli
expand
fallen
favor
gain
ingelheim
lilly
marketed
medicine
medicine’s
offer
panel
Language
unset
Current search:
photo
×
europe
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System